Switching to PegIFNα-2b leads to HBsAg loss in patients with low HBsAg levels and HBV DNA suppressed by NAs.

about

Switching to PegIFNα-2b leads to HBsAg loss in patients with low HBsAg levels and HBV DNA suppressed by NAs.

Item

http://www.wikidata.org/entity/Q42683825

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Switching to PegIFNα-2b leads ...... and HBV DNA suppressed by NAs.

@en

Switching to PegIFNα-2b leads ...... and HBV DNA suppressed by NAs.

@nl

type

Item

label

Switching to PegIFNα-2b leads ...... and HBV DNA suppressed by NAs.

@en

Switching to PegIFNα-2b leads ...... and HBV DNA suppressed by NAs.

@nl

prefLabel

Switching to PegIFNα-2b leads ...... and HBV DNA suppressed by NAs.

@en

Switching to PegIFNα-2b leads ...... and HBV DNA suppressed by NAs.

@nl

P1476

Switching to PegIFNα-2b leads ...... and HBV DNA suppressed by NAs.

@en

P2093

Jing Huang

http://www.w3.org/2001/XMLSchema#string

Jinyao Liao

http://www.w3.org/2001/XMLSchema#string

Ka Zhang

http://www.w3.org/2001/XMLSchema#string

Ren Chen

http://www.w3.org/2001/XMLSchema#string

Wenli Chen

http://www.w3.org/2001/XMLSchema#string

Xiaodan Luo

http://www.w3.org/2001/XMLSchema#string

P2860

Baseline HBsAg predicts response to pegylated interferon-α2b in HBeAg-positive chronic hepatitis B patients.

The influence of hepatitis B and C virus coinfection on liver histopathology in children.

Antiviral therapies and prospects for a cure of chronic hepatitis B.

Interferon Alpha Induces Sustained Changes in NK Cell Responsiveness to Hepatitis B Viral Load Suppression In Vivo.

Durability of Nucleos(t)ide Analogues Treatment in Patients With Chronic Hepatitis B

Hepatitis B surface antigen levels: association with 5-year response to peginterferon alfa-2a in hepatitis B e-antigen-negative patients.

Efficacy of PEGylated Interferon in Treatment-Experienced Chinese Patients With HBeAg Positive Chronic Hepatitis B.

Clinical utility of quantitative HBsAg in natural history and nucleos(t)ide analogue treatment of chronic hepatitis B: new trick of old dog.

Predictors of response to pegylated interferon in chronic hepatitis B: a real-world hospital-based analysis

CONSORT: Effects of adding adefovirdipivoxil to peginterferon alfa-2a at different time points on HBeAg-positivepatients: A prospective, randomized study.

P2888

s41598-017-13747-9

P304

13383

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-017-13747-9

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1092170403

http://www.w3.org/2001/XMLSchema#string

P698

29042662

http://www.w3.org/2001/XMLSchema#string

P932

5645387

http://www.w3.org/2001/XMLSchema#string